newsmetry
rusign inget started
macro

MedCap Q3 net sales up 13%, adjusted EBITA rises 30%

MedCap lifted third-quarter net sales 13% and adjusted EBITA 30%, with growth in every business area, according to TradingView and Reuters.

published on Newsmetry
original source published

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →

Newsmetry newsroom

what happened

Swedish group MedCap reported third-quarter net sales up 13% year on year. Organic growth contributed 5%, with the rest coming from acquisitions. Adjusted EBITA rose 30%.

Reuters reports that all business areas grew. In Assistive Tech, earnings improved mainly thanks to Abilia and LivAssured. In MedTech, the nutrition unit and the Biopsafe acquisition lifted sales. In Specialty Pharma, last year's XGX deal and sales of unlicensed products, which are non-recurring, helped.

TradingView notes that the ECG segment declined year on year. The company expects Specialty Pharma margins to strengthen as products reach more markets and sees favourable prospects for further acquisitions in the near term.

why it matters

The report supports a strategy that pairs acquisitions with organic growth and margin gains. It remains unclear how durable the one-off pharma sales are and whether the company can speed up organic growth. The results matter mainly to investors who follow mid-sized Swedish medtech and pharma companies.

market impact

MedCap and Swedish medtech shares: stronger margins support interest in the company

tags

EarningsStockSweden

instruments

MedCap (MCAP)OMX Stockholm

sources

  1. MedCap (MCAP) Q3 Adjusted EBITA Rose 30%; Sales Up 13% — TradingView, 23 October 2026 at 04:30 UTC
  2. Sweden's MedCap Q3 net sales rise 13%, adjusted EBITA up 30% — Reuters, 23 October 2026 at 04:40 UTC
  3. MCAP: Sales rose 13%, adjusted EBITA 30%, and Q3 margin reached 20.9% — TradingView, 23 October 2026 at 04:47 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.

get stories in real time ↗

related stories